Mercer Island, WA, United States of America

Martin A Cheever

This inventor holds 27 USPTO granted patents and 3 published patent applications and 1 EPO patent, primarily in Cancer Immunotherapy. Top assignees: University of Washington, Corixa Corporation, Washington Research Foundation. Active years: 1994-2013.

USPTO Granted Patents = 27 

% Patents Active = 63.0


Average Co-Inventor Count = 2.0

ph-index = 13

Forward Citations = 696(Granted Patents)


Company Filing History:


Years Active: 1994-2013

Loading Chart...
Loading Chart...
Areas of Expertise:
HER-2/neu Fusion Proteins
Immune Reactivity
WT1 Specific Immunotherapy
Malignancies
Oncogenes
Immunization
Tumor Antigens
Compounds
Diagnosis
Treatment
27 patents (USPTO):Explore Patents

Title: Martin A Cheever - Pioneering Inventor from Mercer Island

Introduction: Martin A Cheever is a distinguished inventor hailing from Mercer Island, Washington. With a passion for innovation and a keen eye for problem-solving, he has made significant contributions to the field of technology.

Latest Patents: Martin A Cheever holds several patents in various technological domains, showcasing his versatility and creativity in inventing cutting-edge solutions to complex challenges.

Career Highlights: Throughout his illustrious career, Martin A Cheever has been recognized for his groundbreaking inventions that have revolutionized industries. His commitment to pushing the boundaries of technology has led to numerous successful ventures.

Collaborations: Martin A Cheever has collaborated with leading tech companies, research institutions, and universities to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: In conclusion, Martin A Cheever stands as a visionary inventor whose innovative spirit continues to inspire the next generation of inventors. His dedication to creating impactful solutions underscores his legacy in the world of technology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…